Order Article Reprints

Sertić Z, Lucijanić M, Bašić-Kinda S, Serventi Seiwerth R, Periša V, Sertić D, Coha B, Pulanić D, Perić Z, Desnica L, et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines. 2022; 10(11):2892. https://doi.org/10.3390/biomedicines10112892

Sertić, Zrinka, Marko Lucijanić, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, Dražen Pulanić, Zinaida Perić, Lana Desnica, and et al. 2022. "Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem" Biomedicines 10, no. 11: 2892. https://doi.org/10.3390/biomedicines10112892

Sertić, Z., Lucijanić, M., Bašić-Kinda, S., Serventi Seiwerth, R., Periša, V., Sertić, D., Coha, B., Pulanić, D., Perić, Z., Desnica, L., Mikulić, M., Vodanović, M., Radman-Livaja, I., Šegulja, D., Rogić, D., Valković, T., Aurer, I., & Duraković, N. (2022). Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines, 10(11), 2892. https://doi.org/10.3390/biomedicines10112892